12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga · 04/04 21:05
Gainers
- Bluejay Diagnostics (NASDAQ:BJDX) stock rose 23.7% to $4.23 during Friday's after-market session. The market value of their outstanding shares is at $2.3 million. As per the news, the Q4 earnings report came out 4 days ago.
- Sensei Biotherapeutics (NASDAQ:SNSE) shares moved upwards by 18.0% to $0.34. The company's market cap stands at $8.4 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) stock increased by 12.82% to $0.44. The market value of their outstanding shares is at $2.7 million.
- Inspire Veterinary (NASDAQ:IVP) stock increased by 12.2% to $1.74. The company's market cap stands at $2.5 million.
- I-MAB (NASDAQ:IMAB) stock moved upwards by 10.29% to $0.75. The market value of their outstanding shares is at $60.6 million. The company's, FY earnings came out yesterday.
- Brainstorm Cell (NASDAQ:BCLI) shares rose 8.62% to $1.26. The market value of their outstanding shares is at $7.1 million. The company's, Q4 earnings came out 4 days ago.
Losers
- Impact BioMedical (AMEX:IBO) stock declined by 17.9% to $0.79 during Friday's after-market session. The market value of their outstanding shares is at $9.0 million.
- Protagenic Therapeutics (NASDAQ:PTIX) stock declined by 14.19% to $0.33. The market value of their outstanding shares is at $2.4 million. The company's, Q4 earnings came out 4 days ago.
- P3 Health Partners (NASDAQ:PIII) shares fell 10.41% to $0.15. The company's market cap stands at $24.9 million.
- Verrica Pharmaceuticals (NASDAQ:VRCA) shares declined by 9.44% to $0.48. The market value of their outstanding shares is at $44.0 million.
- China Pharma Holding (AMEX:CPHI) stock decreased by 7.57% to $0.21. The company's market cap stands at $3.9 million.
- Predictive Oncology (NASDAQ:POAI) stock fell 7.47% to $1.24. The company's market cap stands at $8.9 million. The company's, Q4 earnings came out 3 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.